CDA’s goal is to help advance junior clinical research scientists in their professional endeavors to cure retinal degenerative disease by: (1) facilitating advances in laboratory and clinical research; (2) elucidating the mechanism for the cause and pathogenesis of retinal degenerative diseases; (3) developing innovative strategies to prevent, treat and cure these diseases. This program supports up to five junior-level faculty for five (5) years at $75,000/year. Clinician-scientists possessing an M.D., D.O., O.D., or recognized equivalent foreign degree and who are in their first, second, or third year of a junior faculty appointment, and are committed to solving the mysteries of inherited retinal diseases are encouraged to apply for a CDA. Individuals from underrepresented racial, ethnic and gender groups, as well as individuals with disabilities, are always encouraged to apply.
All prospective award recipients must submit an application via the Foundation’s online application portal. Application guidelines should be downloaded and reviewed before beginning your letter or application. Accepting applications Fall 2021.
Research progress and accomplishments are tracked during the funding period through Scientific Progress and Financial reports. All reports should be uploaded to the Foundation’s reporting portal.